Publicaciones en colaboración con investigadoras/es de Icahn School of Medicine at Mount Sinai (11)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. Genome-wide data from medieval German Jews show that the Ashkenazi founder event pre-dated the 14th century

    Cell, Vol. 185, Núm. 25, pp. 4703-4716

  2. Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic- a systematic review

    European Neuropsychopharmacology, Vol. 54, pp. 90-99

2021

  1. Corrigendum to “Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action [European Neuropsychopharmacology (2020) 36, 121–136]” (European Neuropsychopharmacology (2020) 36 (121–136), (S0924977X20301802), (10.1016/j.euroneuro.2020.05.006))

    European Neuropsychopharmacology

  2. DSM-5 and ICD-11 criteria for bipolar disorder: Implications for the prevalence of bipolar disorder and validity of the diagnosis – A narrative review from the ECNP bipolar disorders network

    European Neuropsychopharmacology, Vol. 47, pp. 54-61

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Changes in Day/Night Activity in the 6-OHDA-Induced Experimental Model of Parkinson’s Disease: Exploring Prodromal Biomarkers

    Frontiers in Neuroscience, Vol. 14

  2. Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action

    European Neuropsychopharmacology, Vol. 36, pp. 121-136

2014

  1. Extracellular matrix and liver disease

    Antioxidants and Redox Signaling, Vol. 21, Núm. 7, pp. 1078-1097

2011

  1. Loss of discoidin domain receptor 2 promotes hepatic fibrosis after chronic carbon tetrachloride through altered paracrine interactions between hepatic stellate cells and liver-associated macrophages

    American Journal of Pathology, Vol. 179, Núm. 6, pp. 2894-2904

2010

  1. Dysregulation of the mTOR pathway mediates impairment of synaptic plasticity in a mouse model of Alzheimer's disease

    PLoS ONE, Vol. 5, Núm. 9, pp. 1-10